Mednet Logo
HomeNeurologyQuestion

What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers?

2
2 Answers
Mednet Member
Mednet Member
Rheumatology · Arthritis and Rheumatism Associates, P.C.

A timely question, as we head to 2023! The only reason to use biosimilars is for the broad purpose of resource stewardship. There isn't a medical reason to prefer a biosimilar over a reference product (or vice versa), because if a product were found to have a significantly different therapeutic effe...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Northwestern University - The Feinberg School of Medicine

For those interested, there is an upcoming webinar by the Arthritis Foundation discussing the usage of biosimilars in inflammatory arthritis. It is on 11/9/2022, 6-7PM ET. Further details at the link below:

https://www.arthritis.org/events/webinars/upcoming-webinars

This may provide further informat...

Register or Sign In to see full answer

What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers? | Mednet